Glow 60 mg

Glow Blend 60mg — BPC-157, TB-500 and GHK-Cu by Dragon Pharma

Glow Blend is Dragon Pharma's triple-peptide formulation combining BPC-157, TB-500 and GHK-Cu in a single 60mg vial at $200. By adding GHK-Cu to the established BPC-157 + TB-500 recovery duo, Glow Blend extends the combination into a third independent biological pathway — collagen and extracellular matrix remodelling — making it the aesthetics-focused peptide blend in the Dragon Pharma range.

Also searched as: Glow Blend 60mg, BPC-157 TB-500 GHK-Cu blend, triple peptide recovery skin blend, Glow Blend Dragon Pharma.

Why GHK-Cu Adds a Third Independent Pathway

The critical information gap in most descriptions of this blend — why GHK-Cu adds meaningful new function rather than simply more of the same:

BPC-157 and TB-500 address tissue repair from complementary angles — one localised, one systemic. GHK-Cu addresses a different problem: the quality and density of the extracellular matrix (collagen, elastin, glycosaminoglycans) that supports tissue long-term. Together the three provide repair initiation (BPC-157), systemic healing mobilisation (TB-500) and structural matrix remodelling (GHK-Cu) — three independent biological programmes in a single injection.

Glow Blend vs Klow Blend — Which to Choose

Dragon Pharma offers two multi-peptide blends with overlapping but distinct compositions:

The practical decision: if the primary goal is skin quality, collagen density and aesthetic tissue remodelling, Glow Blend's three pathways cover the relevant biology. If the goal includes managing inflammatory conditions, injury recovery with immune components or gut-related concerns, Klow Blend's addition of KPV provides the NF-κB immune modulation pathway that Glow Blend lacks.

Why Glow Blend Is Specifically Suited to Aesthetic Applications

The aesthetic application — skin quality, anti-aging, post-procedure healing — benefits specifically from the Glow Blend composition:

• BPC-157 accelerates wound healing and angiogenesis at and near the skin surface — relevant for post-procedure skin recovery (after aesthetic treatments, microneedling, laser, etc.)
• TB-500 provides systemic anti-inflammatory and cell migration support — reducing systemic inflammation that accelerates skin aging and supporting repair across the skin's dermal layer regardless of injection site
• GHK-Cu drives collagen and elastin synthesis via TGF-β — directly addressing the collagen loss that underlies skin aging, wrinkle formation and loss of skin density. At its nanomolar biological activity threshold, meaningful fibroblast stimulation is achievable at the doses in the blend

Effects and Benefits

• Localised tissue repair from BPC-157 — particularly relevant near skin treatment sites or scarring
• Systemic anti-inflammatory and cell migration support from TB-500
• Collagen and elastin synthesis via GHK-Cu's TGF-β activation — the primary driver of improved skin density and texture
• GHK-Cu's documented 4,000+ gene modulation includes antioxidant, repair and anti-inflammatory gene expression shifts
• No suppression of natural testosterone — no PCT required

Dosage and Administration

Given the blend's localised (BPC-157) and systemic (TB-500, GHK-Cu) components, injection site has a moderate influence — injecting near an area of skin concern takes advantage of BPC-157's localised mechanism, while TB-500 and GHK-Cu work systemically regardless. Reconstitute with bacteriostatic water. Store refrigerated at 2-8°C after reconstitution for up to 28-30 days. Never freeze.